The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON-107 study

Authors :: Greef, G.E. (Georgine) de
Braakman, E. (Eric)
Holt, B. (Bronno) van der
Janssen, J.J.W.M. (Jeroen)
Petersen, E.J. (Eefke)
Vucinic, V. (Vladimir)
Thuss, N. (Nicole)
Grootes, M.E.
Cornelissen, J.J. (Jan)
Greef, G.E. (Georgine) de
Braakman, E. (Eric)
Holt, B. (Bronno) van der
Janssen, J.J.W.M. (Jeroen)
Petersen, E.J. (Eefke)
Vucinic, V. (Vladimir)
Thuss, N. (Nicole)
Grootes, M.E.
Cornelissen, J.J. (Jan)
Publication Year :: 2018
Abstract: Background: Plerixafor (PFX) mobilizes CD34+ cells into circulation by disrupting the CXCR4 binding of the hematopoietic stem cell in its bone marro

Full Text Access

Tools